A phase II study of weekly docetaxel combined with carboplatin for elderly patients with advanced non-small cell lung cancer

被引：0
|
作者：
Son, C. [1 ]
Kim, K. [1 ]
Lee, K. [1 ]
Yang, D. [1 ]
Lee, S. [1 ]
Choi, P. [1 ]
Cho, S. [1 ]
机构：
[1] Dong A Univ, Busan, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
18174
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase I/II study of carboplatin and weekly paclitaxel for advanced non-small cell lung cancer.
    Ohashi, N
    Arita, KI
    Daga, H
    Mito, A
    Nishino, R
    Moritani, C
    Nakamura, K
    Daido, K
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 687S - 687S
  • [32] Phase I trial of weekly docetaxel in elderly patients with non-small cell lung cancer
    Inoue, A
    Kunitoh, H
    Mori, K
    Nukiwa, T
    Fukuoka, M
    Saijo, N
    LUNG CANCER, 2002, 38 (02) : 205 - 209
  • [33] A phase I/II study of bexarotene with carboplatin and weekly paclitaxel for the treatment of patients with advanced non-small cell lung cancer
    Dragnev, Konstantin H.
    Whyman, Jeremy D.
    Hahn, Cynthia K.
    Kebbekus, Peter E.
    Kokko, Sarah F.
    Bhatt, Sunil M.
    Rigas, James R.
    JOURNAL OF THORACIC DISEASE, 2018, 10 (09) : 5531 - 5537
  • [34] Phase II study of cetuximab in combination with carboplatin and docetaxel for patients with advanced/metastatic non-small cell lung cancer (NSCLC)
    Belani, C. P.
    Ramalingam, S.
    Schreeder, M.
    Steis, R.
    Guidice, R.
    Marshland, T.
    Butler, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [35] Phase I trial of bi-weekly docetaxel combined with carboplatin for patients with non-small cell lung cancer.
    Inoue, A
    Ishida, T
    Saijo, Y
    Maemondo, M
    Suzuki, T
    Kimura, Y
    Ohkouchi, S
    Nukiwa, T
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 676S - 676S
  • [36] A PHASE I/II STUDY OF BEXAROTENE WITH WEEKLY PACLITAXEL AND CARBOPLATIN FOR THE TREATMENT OF PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Whyman, Jeremy D.
    Kebbekus, Peter E.
    Fink, Sarah K.
    Rigas, James R.
    Dragnev, Konstantin H.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S883 - S883
  • [37] Biweekly administration of docetaxel and gemcitabine for elderly patients with advanced non-small cell lung cancer: A phase II study
    Syrigos, K. N.
    Karapanagiotou, E.
    Charpidou, A.
    Dilana, K.
    Dannos, I.
    Dionellis, G.
    Rigopoulou, A.
    Georgatou, N.
    Roussos, C.
    JOURNAL OF CHEMOTHERAPY, 2007, 19 (04) : 438 - 443
  • [38] A phase I study of weekly docetaxel and cisplatin in advanced non-small cell lung cancer
    Sato, K
    Tsuchiya, S
    Minato, K
    Takei, Y
    Watanabe, S
    Saitoh, R
    Mori, M
    LUNG CANCER, 2001, 33 (01) : 69 - 73
  • [39] A study of weekly docetaxel and carboplatin as first-line chemotherapy for advanced non-small cell lung cancer
    Jiang, Haiping
    Zhang, Xiaochen
    Chen, Jing
    Zhang, Ling
    Xiong, Jianping
    Zhong, Lin
    Yu, Feng
    Qian, Jiong
    Yu, Lanfang
    Wang, Xiaoting
    Shi, Genming
    Deng, Jing
    Xu, Nong
    JOURNAL OF THORACIC DISEASE, 2014, 6 (02) : 79 - 85
  • [40] A phase II trial of weekly cisplatin and docetaxel in advanced non-small cell lung cancer (NSCLC)
    Sovak, M. A.
    Lutzker, S.
    Guensch, L.
    Joyce, M.
    Schwartz, S.
    Wu, Y.
    Zheng, L.
    Aisner, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345